Citlally Condado-Huerta, Adriana López-Barradas, Alan Hernández-Melgar, Rommel A Carballo-Castañeda, Raúl De la Torre-Baez, Maria R Encarnacion-Garcia, Mónica Sánchez-Tapia, Omar Granados-Portillo, Lilia G Noriega, Natalia Vázquez-Manjarrez, Martha Guevara-Cruz, Nimbe Torres, Juan Carlos León-Contreras, Guillermina Juliana Baay-Guzman, Oscar Rodríguez-Lima, Abraham Landa, Porfirio Nava, Aldo Moreno-Ulloa, Armando R Tovar, Francisco Flores-Murrieta, Laura A Velazquez-Villegas
{"title":"Intermittent fasting reduces obesity-driven oxidative stress in the male mouse colon via changes in gut microbiota.","authors":"Citlally Condado-Huerta, Adriana López-Barradas, Alan Hernández-Melgar, Rommel A Carballo-Castañeda, Raúl De la Torre-Baez, Maria R Encarnacion-Garcia, Mónica Sánchez-Tapia, Omar Granados-Portillo, Lilia G Noriega, Natalia Vázquez-Manjarrez, Martha Guevara-Cruz, Nimbe Torres, Juan Carlos León-Contreras, Guillermina Juliana Baay-Guzman, Oscar Rodríguez-Lima, Abraham Landa, Porfirio Nava, Aldo Moreno-Ulloa, Armando R Tovar, Francisco Flores-Murrieta, Laura A Velazquez-Villegas","doi":"10.1016/j.jcmgh.2025.101592","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and aims: </strong>Obesity impairs colon homeostasis by increasing oxidative stress, which is associated with damage to the epithelial barrier and the development of intestinal diseases. Intermittent fasting (IF) improves mitochondrial activity (MA) in metabolic tissues and positively modifies gut microbiota composition, suggesting that this intervention may exert beneficial effects on colon homeostasis. The aim of this study was to evaluate the effect of IF on MA in the colon and its modulation by gut microbiota in a diet-induced obesity mouse model.</p><p><strong>Methods: </strong>C57BL/6 male mice were fed a control (CNT) diet or high-fat/high-sucrose diet (HFSD) for 12 weeks, followed by 4 weeks of IF intervention or continued HFSD, with or without antibiotic (AB) treatment. We evaluated MA in colonic mitochondria determined by the oxygen consumption rate (OCR) and reactive oxygen species (ROS) production, together with gut microbiota composition and metabolome from feces.</p><p><strong>Results: </strong>Mice who underwent IF intervention had a significant decrease in colonic mitochondria OCR and ROS compared to the HFSD group, parameters that were sharply increased by AB administration. Moreover, IF improved colon morphology and epithelial barrier integrity via changes in gut microbiota composition and the metabolome profile, an effect that was modulated by mitochondrial activity and ROS production and not preserved upon AB administration.</p><p><strong>Conclusions: </strong>We conclude that IF reduces MA in the colon via changes in bacterial taxonomy and metabolites abundance to decrease oxidative stress caused by obesity, establishing a close connection between host MA and gut microbiota.</p>","PeriodicalId":55974,"journal":{"name":"Cellular and Molecular Gastroenterology and Hepatology","volume":" ","pages":"101592"},"PeriodicalIF":7.1000,"publicationDate":"2025-07-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cellular and Molecular Gastroenterology and Hepatology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.jcmgh.2025.101592","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background and aims: Obesity impairs colon homeostasis by increasing oxidative stress, which is associated with damage to the epithelial barrier and the development of intestinal diseases. Intermittent fasting (IF) improves mitochondrial activity (MA) in metabolic tissues and positively modifies gut microbiota composition, suggesting that this intervention may exert beneficial effects on colon homeostasis. The aim of this study was to evaluate the effect of IF on MA in the colon and its modulation by gut microbiota in a diet-induced obesity mouse model.
Methods: C57BL/6 male mice were fed a control (CNT) diet or high-fat/high-sucrose diet (HFSD) for 12 weeks, followed by 4 weeks of IF intervention or continued HFSD, with or without antibiotic (AB) treatment. We evaluated MA in colonic mitochondria determined by the oxygen consumption rate (OCR) and reactive oxygen species (ROS) production, together with gut microbiota composition and metabolome from feces.
Results: Mice who underwent IF intervention had a significant decrease in colonic mitochondria OCR and ROS compared to the HFSD group, parameters that were sharply increased by AB administration. Moreover, IF improved colon morphology and epithelial barrier integrity via changes in gut microbiota composition and the metabolome profile, an effect that was modulated by mitochondrial activity and ROS production and not preserved upon AB administration.
Conclusions: We conclude that IF reduces MA in the colon via changes in bacterial taxonomy and metabolites abundance to decrease oxidative stress caused by obesity, establishing a close connection between host MA and gut microbiota.
期刊介绍:
"Cell and Molecular Gastroenterology and Hepatology (CMGH)" is a journal dedicated to advancing the understanding of digestive biology through impactful research that spans the spectrum of normal gastrointestinal, hepatic, and pancreatic functions, as well as their pathologies. The journal's mission is to publish high-quality, hypothesis-driven studies that offer mechanistic novelty and are methodologically robust, covering a wide range of themes in gastroenterology, hepatology, and pancreatology.
CMGH reports on the latest scientific advances in cell biology, immunology, physiology, microbiology, genetics, and neurobiology related to gastrointestinal, hepatobiliary, and pancreatic health and disease. The research published in CMGH is designed to address significant questions in the field, utilizing a variety of experimental approaches, including in vitro models, patient-derived tissues or cells, and animal models. This multifaceted approach enables the journal to contribute to both fundamental discoveries and their translation into clinical applications, ultimately aiming to improve patient care and treatment outcomes in digestive health.